Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 16.18% is 33% above its 5-year average of 12.16%, near the high end of its 5-year range (1.09%–16.18%).
As of the fiscal period ended Tuesday, June 30, 2026. 19.47% above its 12-month average of 13.54%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 16.18%.
DEBT TO ASSETS RATIO
16.18%
DEBT TO ASSETS RATIO AVG TTM
13.54%
DEBT TO ASSETS RATIO AVG 3Y
12.94%
DEBT TO ASSETS RATIO AVG 5Y
12.16%
DEBT TO ASSETS RATIO AVG 10Y
11.90%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+19.47%
CURRENT VS 3Y AVG
+25.08%
CURRENT VS 5Y AVG
+33.12%
CURRENT VS 10Y AVG
+35.99%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.13%
median of 386 covered companies
CURRENT VS SECTOR MEDIAN
+12347.60%
vs the sector median at left
aTyr Pharma, Inc.
Market Cap
$28.43M
Debt to Assets Ratio
16.18%
TTM Avg
13.54%
3Y Avg
12.94%
5Y Avg
12.16%
Market Cap
$30.92M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$31.36M
Debt to Assets Ratio
0.19%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$25.48M
Debt to Assets Ratio
0.09%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$32.31M
Debt to Assets Ratio
1.40%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$24.44M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$33.42M
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| aTyr Pharma, Inc. (ATYR) | $28.43M | 16.18% | 13.54% | 12.94% | 12.16% |
| CervoMed Inc. (CRVO)vs › | $30.65M | 0.00% | N/A | N/A | N/A |
| Context Therapeutics Inc. (CNTX)vs › | $30.92M | 0.01% | N/A | N/A | N/A |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.36M | 0.19% | N/A | N/A | N/A |
| ABVC BioPharma, Inc. (ABVC)vs › | $25.48M | 0.09% | N/A | N/A | N/A |
| EUDA Health Holdings Limited (EUDA)vs › | $32.31M | 1.40% | N/A | N/A | N/A |
| BeyondSpring Inc. (BYSI)vs › | $32.32M | 0.01% | N/A | N/A | N/A |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.44M | 0.00% | N/A | N/A | N/A |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.42M | 0.05% | N/A | N/A | N/A |
| Aytu BioPharma, Inc. (AYTU)vs › | $21.90M | 0.17% | N/A | N/A | N/A |
Debt/Assets
16.2%
Debt/Equity
0.23
Current Ratio
5.12
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 16.18% |
| 2026-03-31 | 14.69% |
| 2025-12-31 | 12.78% |
| 2025-09-30 | 11.59% |
| 2025-06-30 | 12.49% |
| 2025-03-31 | 13.36% |
| 2024-12-31 | 13.72% |
| 2024-09-30 | 14.81% |
| 2024-06-30 | 13.07% |
| 2024-03-31 | 12.47% |
| 2023-12-31 | 12.51% |
| 2023-09-30 | 12.17% |
| 2023-06-30 | 11.59% |
| 2023-03-31 | 10.44% |
| 2022-12-31 | 12.04% |
| 2022-09-30 | 9.01% |
| 2022-06-30 | 1.33% |
| 2022-03-31 | 1.09% |
| 2021-12-31 | 1.19% |
| 2021-09-30 | 1.30% |
| 2021-06-30 | 3.72% |
| 2021-03-31 | 3.69% |
| 2020-12-31 | 5.78% |
| 2020-09-30 | 13.21% |
| 2020-06-30 | 16.00% |
| 2020-03-31 | 17.78% |
| 2019-12-31 | 32.42% |
| 2019-09-30 | 31.44% |
| 2019-06-30 | 32.31% |
| 2019-03-31 | 35.51% |
| 2018-12-31 | 30.39% |
| 2018-09-30 | 29.79% |
| 2018-06-30 | 28.64% |
| 2018-03-31 | 25.46% |
| 2017-12-31 | 22.08% |
| 2017-09-30 | 15.61% |
| 2017-06-30 | 23.71% |
| 2017-03-31 | 14.56% |
| 2016-12-31 | 11.84% |
| 2016-09-30 | 3.07% |
| 2016-06-30 | 3.47% |
| 2016-03-31 | 3.76% |
| 2015-12-31 | 3.97% |
| 2015-09-30 | 4.21% |
| 2015-06-30 | 4.40% |
| 2015-03-31 | 15.88% |
| 2014-12-31 | 49.78% |
| 2014-09-30 | 41.21% |
| 2013-12-31 | 17.31% |
